A detailed history of Journey Strategic Wealth LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 645 shares of UTHR stock, worth $232,761. This represents 0.01% of its overall portfolio holdings.

Number of Shares
645
Previous 629 2.54%
Holding current value
$232,761
Previous $200,000 15.5%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $4,976 - $5,816
16 Added 2.54%
645 $231,000
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $143,575 - $200,676
629 New
629 $200,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Journey Strategic Wealth LLC Portfolio

Follow Journey Strategic Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Strategic Wealth LLC with notifications on news.